Transpact Enterprises Stock Screener | Share Price & Fundamental Analysis
TRANSPACT
Medical Equipment
Screen Transpact Enterprises share price with our stock screener - analyze fundamentals and track trades in your journal
Market Cap
₹5.32 Cr.
P/B Ratio
12.37
EPS (TTM)
₹0.23
Dividend Yield
-
Debt to Equity
0.17
52W High
-
52W Low
-
Operating Margin
-
Profit Margin
-
EBITDA
-
Net Income
-
Total Assets
₹1.00
Total Equity
₹1.00
Transpact Enterprises Share Price History - Stock Screener Chart
Screen TRANSPACT historical share price movements with interactive charts. Analyze price trends and patterns.
Transpact Enterprises Company Profile - Fundamental Screener
Screen Transpact Enterprises company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for TRANSPACT shares.
Sector
Healthcare
Industry
Medical Equipment
Sub-Sector
Medical Equipment
Segment
E
ISIN
INE06YD01010
Transpact Enterprises Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen TRANSPACT balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
| Current Assets | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Liabilities | ||||||||||
| Total Liabilities | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 |
| Share Capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves & Surplus | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
Screen TRANSPACT income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit % | 0.00% | 50.00% | 0.00% | -8.00% | -139.00% | -196.00% | 0.00% | -28.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS | 0.00 | 0.23 | -2.35 | -1.70 | -5.71 | -1.66 | -11.20 | -10.55 | 0.00 | 0.00 | 0.00 | 0.00 |
Transpact Enterprises Cash Flow Screener - Liquidity Fundamentals
Screen TRANSPACT cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 0 | 0 | 0 | -1 | 0 | -1 | 0 | 0 | 0 | 0 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Activities | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 |
Screen TRANSPACT shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Sept | 2025-Mar | 2024-Sept | 2024-Mar | 2023-Sept | 2023-Mar | 2022-Sept | 2022-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 0.13% | 16.16% | 16.16% | 18.23% | 32.20% | 32.63% | 45.89% | 45.89% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 66.37% | 61.33% | 54.35% | 64.95% | 53.40% | 61.97% | 31.94% | 31.94% |
| Other Holding | 33.49% | 22.50% | 29.49% | 16.82% | 14.40% | 5.39% | 22.16% | 22.16% |
| Shareholder Count | 123 | 129 | 143 | 119 | 114 | 62 | 37 | 37 |
Transpact Enterprises Dividend Screener - Share Yield Analysis
Screen TRANSPACT dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Transpact Enterprises Index Membership - Market Screener Classification
Screen TRANSPACT by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Transpact Enterprises Market Events Screener - Corporate Actions
Screen TRANSPACT market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Quarterly Result Announcement | NA | 10.23% | ||
| Annual General Meeting | NA | -2.63% | ||
| Annual General Meeting | NA | 8.83% | ||
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -18.50% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | -0.63% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | 0.93% |
| 2024-04-12 | 2024-04-12 | Extraordinary General Meeting | NA | -3.59% |
Transpact Enterprises Competitors Screener - Peer Comparison
Screen TRANSPACT competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Poly Medicure | 18,011 | 50.52 | 1,759 | 22.62% | 339 | 45.27 |
| Laxmi Dental | 1,373 | 54.66 | 242 | 24.12% | 25 | 34.01 |
| Tarsons Products | 1,194 | 58.73 | 408 | 32.64% | 30 | 36.93 |
| Vasa Denticity | 955 | 63.77 | 173 | % | 15 | 41.01 |
| Osel Devices | 928 | 47.93 | 187 | 40.62% | 20 | 34.59 |
| Fabtech Technologies | 856 | 18.73 | 336 | 45.66% | 47 | 32.03 |
| Prevest Denpro | 582 | 31.21 | 67 | 13.15% | 18 | 51.16 |
| Aprameya Engineering | 502 | 28.83 | 136 | 107.77% | 16 | 35.25 |
| Hemant Surgical Industries | 352 | 44.96 | 112 | % | 8 | 38.77 |
| Nureca | 293 | 72.08 | 122 | 19.24% | 1 | 51.10 |
Transpact Enterprises Company Announcements - News Screener
Screen TRANSPACT latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-11-14 | Board Meeting Outcome for Board Meeting Outcome For Adoption Of Unaudited Financial Results For The Half Year Ended September 30 2025. | View |
| 2025-11-10 | Board Meeting Intimation for Board Meeting To Be Held On Friday 14Th November 2025 At 04:00 P.M. | View |
| 2025-10-13 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-07 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-10-01 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-30 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-24 | Closure of Trading Window | View |
| 2025-09-08 | Intimation Of Book Closure For 12Th AGM | View |
| 2025-09-06 | Notice Of 12Th Annual General Meeting To Be Held On 29Th September 2025 At 04:00 P.M. | View |
| 2025-09-06 | Reg. 34 (1) Annual Report. | View |
| 2025-09-04 | Board Meeting Outcome for Outcome Of Board Meeting Held On 4Th September 2025 At 04:00 P.M. | View |
| 2025-09-01 | Board Meeting Intimation for Board Meeting To Be Held On September 4 2025 At 04:00 P.M. | View |
| 2025-08-30 | Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 | View |
| 2025-07-22 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-05-30 | Board Meeting Outcome for Board Meeting Held On 30Th May 2025 For Adopting Audited Financial Results Taking Note Of Resignation Of CFO & Appointment Of CFO. | View |
| 2025-05-29 | Resignation From The Office Of The Chief Financial Officer (CFO) Of The Company With Effect From 27Th May 2025. | View |
| 2025-05-27 | Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) | View |
| 2025-05-23 | Board Meeting Intimation for Considering The Audited Financial Results For Half Year & Year Ended 31St March 2025 | View |
| 2025-05-13 | Board Meeting Outcome for Appointment Of Ms. Priya Goel As Additional (Non Executive Independent) Director Of The Company | View |
| 2025-04-30 | Compliance Certificate For The Period Ended 31 March 2025 | View |